Anti-Insulin Receptor Autoantibodies and Type 2 Diabetes in Mice
Author Information
Author(s): Marcia F. McInerney, Sonia M. Najjar, Deanna Brickley, Mary Lutzke, George A. Abou-Rjaily, Peter Reifsnyder, Bradford D. Haskell, Kevin Flurkey, Ying-Jian Zhang, Susan L. Pietropaolo, Massimo Pietropaolo, James P. Byers, Edward H. Leiter
Primary Institution: University of Toledo College of Pharmacy
Hypothesis
Are anti-insulin receptor autoantibodies required for the development of type 2 diabetes in NZO mice?
Conclusion
Anti-insulin receptor autoantibodies are not essential for the development of insulin resistance or diabetes in NZO mice.
Supporting Evidence
- 50% of NZO/HlLt males develop diabetes by 24 weeks.
- B lymphocyte-deficient mice did not show significant differences in diabetes development compared to wild-type.
- Autoantibodies were present in diabetic but not normoglycemic mice.
Takeaway
The study found that certain antibodies in mice don't actually cause diabetes, even though they are often thought to be linked.
Methodology
The study involved creating a new mouse strain and comparing the development of diabetes in mice with and without specific autoantibodies.
Potential Biases
Potential bias due to the specific genetic backgrounds of the mouse strains used.
Limitations
The study's findings may not be generalizable beyond the specific mouse strains used.
Participant Demographics
NZO/HlLt male and female mice, aged 16 to 28 weeks.
Statistical Information
P-Value
<0.0005
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website